ZYKADIA
ceritinib
Listed by Novartis Pharmaceuticals Corporation
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Ceritinib 150 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0078-0694 |
| FDA application | NDA211225 |
| RxNorm concept | 2121059 |
| Package sizes listed | 2 |
| Marketed since | March 2019 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.